Impact of psychosis in bipolar disorder during manic episodes^*

References

• Bora E, Yücel M, Pantelis C. Neurocognitive markers of psychosis in bipolar disorder: a meta-analytic study. J Affect Disord. 2010;127(1–3):1–9.
   PubMed Web of Science ®Google Scholar
• Coryell W, Leon AC, Turvey C, et al. The significance of psychotic features in manic episodes: a report from the NIMH collaborative study. J Affect Disord. 2001;67(1):79–88.
   PubMed Web of Science ®Google Scholar
• Rosenthal NE, Rosenthal LN, Stallone F, et al. Psychosis as a predictor of response to lithium maintenance treatment in bipolar affective disorder. J Affect Disord. 1979;1(4):237–245.
   PubMed Web of Science ®Google Scholar
• Demmo C, Lagerberg TV, Aminoff SR, et al. History of psychosis and previous episodes as potential explanatory factors for neurocognitive impairment in first‐treatment bipolar I disorder. Bipolar Disord. 2016;18(2):136–147.
   PubMed Web of Science ®Google Scholar
• Dunayevich E, Keck PE. Prevalence and description of psychotic features in bipolar mania. Curr Psychiatr Rep. 2000;2(4):286–290.
   PubMedGoogle Scholar
• Keck PE, McElroy SL, Havens JR, et al. Psychosis in bipolar disorder: phenomenology and impact on morbidity and course of illness. Compr Psychiatr. 2003;44(4):263–269.
   PubMed Web of Science ®Google Scholar
• McElroy SL, Keck Jr PE, Strakowski SM. Mania, psychosis, and antipsychotics. J Clin Psychiatr. 1995;57:14–26.
   Web of Science ®Google Scholar
• Potash JB, Willour VL, Chiu Y-F, et al. The familial aggregation of psychotic symptoms in bipolar disorder pedigrees. Am J Psychiatr . 2001;158(8):1258–1264.
   PubMed Web of Science ®Google Scholar
• de Vries FM, Denig P, Pouwels KB, et al. Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: a meta-analysis. Drugs. 2012;72(18):2365–2373.
   PubMed Web of Science ®Google Scholar
• Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366(9493):1267–1278.
   PubMed Web of Science ®Google Scholar
• Carlson GA, Goodwin FK. The stages of mania. A longitudinal analysis of the manic episode . Arch Gen Psychiatr. 1973;28(2):221–228.
   PubMed Web of Science ®Google Scholar
• Rosen LN, Rosenthal NE, Dunner DL, et al. Social outcome compared in psychotic and nonpsychotic bipolar I patients. J Nerv Ment Dis. 1983;171(5):272–275.
   PubMed Web of Science ®Google Scholar
• Canuso CM, Bossie CA, Zhu Y, et al. Psychotic symptoms in patients with bipolar mania. J Affect Disord. 2008;111(2–3):164–169.
   PubMed Web of Science ®Google Scholar
• First M, Williams J, Karg R, et al. Structured clinical interview for DSM-5 – Research version (SCID-5 for DSM-5, research version; SCID-5-RV). Arlington: American Psychiatric Association; 2015.
   Google Scholar
• Young R, Biggs J, Ziegler V, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatr. 1978;133(5):429–435.
   PubMed Web of Science ®Google Scholar
• Hallit S, Obeid S, Haddad C, et al. Validation of the Arabic Version of the PANSS Scale among Lebanese Schizophrenic Patients. J Psychopathol. 2017;23:60–66.
   Web of Science ®Google Scholar
• Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–276.
   PubMed Web of Science ®Google Scholar
• Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont). 2007;4(7):28–37.
   PubMedGoogle Scholar
• Pope HG, Lipinski JF. Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of 'schizophrenic' symptoms in the light of current research . Arch Gen Psychiatr. 1978;35(7):811–828.
   PubMed Web of Science ®Google Scholar
• Goodwin F, Jamison K. Manic-depressive illness. New York: Oxford University Press; 1990. p. 186–209.
   Google Scholar
• Manji HK, Quiroz JA, Payne JL, et al. The underlying neurobiology of bipolar disorder. World Psychiatr. 2003;2(3):136.
   PubMedGoogle Scholar
• Yiannakopoulou E, Papadopulos JS, Cokkinos DV, et al. Adherence to antihypertensive treatment: a critical factor for blood pressure control. Eur J Cardiovasc Prev Rehabil. 2005;12(3):243–249.
   PubMedGoogle Scholar
• Healthline. Understanding psychosis in bipolar disorder, updated in November 14, 2016 [cited 2017 Apr 4]. Available from: http://www.healthline.com/health/bipolar-disorder/bipolar-psychosis#overview1, [last accessed Apr 4, 2017].
   Google Scholar
• Tohen M, Waternaux CM, Tsuang MT. Outcome in mania: a 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psychiatr. 1990;47(12):1106–1111.
   PubMed Web of Science ®Google Scholar
• Tohen M, Tsuang MT, Goodwin DC. Prediction of outcome in mania by mood-congruent or mood-incongruent psychotic features. Am J Psychiatr. 1992;149:1580
   PubMed Web of Science ®Google Scholar
• Goldberg JF, Harrow M, Grossman LS. Recurrent affective syndromes in bipolar and unipolar mood disorders at follow-up. Br J Psychiatr. 1995; 166(3):382–385.
   PubMed Web of Science ®Google Scholar
• Ketter TA, Wang PW, Becker OV, et al. Psychotic bipolar disorders: dimensionally similar to or categorically different from schizophrenia? J Psychiatr Res. 2004;38(1):47–61.
   PubMed Web of Science ®Google Scholar
• Lowe GR. The phenomenology of hallucinations as an aid to differential diagnosis. Br J Psychiatr. 1973;123(577):621–633.
   PubMed Web of Science ®Google Scholar
• Rosen LN, Rosenthal NE, Van Dusen PH, et al. Age at onset and number of psychotic symptoms in bipolar I and schizoaffective disorder. Am j psychiatr. 1983;140(11):1523–4.
   PubMed Web of Science ®Google Scholar
• Tohen M, Waternaux CM, Tsuang MT, et al. Four-year follow-up of twenty-four first-episode manic patients. J Affect Disord. 1990;19(2):79–86.
   PubMed Web of Science ®Google Scholar